National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals
Westgard L, Sato T, Bradford W, Eaton E, Pilcher F, Hale A, Singh D, Martin M, Appa A, Meyer J, Weimer M, Barakat L, Felsen U, Akiyama M, Ridgway J, Grussing E, Thakarar K, White A, Mutelayi J, Krsak M, Montague B, Nijhawan A, Balakrishnan H, Marks L, Wurcel A. National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals. Open Forum Infectious Diseases 2024, 11: ofae204. PMID: 38746950, PMCID: PMC11093397, DOI: 10.1093/ofid/ofae204.Peer-Reviewed Original ResearchScreening ratesHepatitis C virusTesting ratesHepatitis C virus screening ratesHIV screening ratesHIV testing ratesOpt-out testing policyHCV screening ratesStatistically significant differenceHepatitis C virus antibody testingInjection drug useAssociated with statistically significant differencesViral load testingNational HIVHospital sitesHCV antibody testingInpatient encountersUS hospitalsSignificant differenceInpatient hospitalizationU.S. hospitalsInpatient testingPWUDHospitalized peopleHospital